Sun Pharma posts content of USFDA warning letter
Sun Pharma said that there were no serious issues in the USFDA warning letter, and no data integration issues were raised. Consequently, the scrip rose 3% on BSE.
Other Corporate Videos
TCS screening candidates for C-suite rejig ahead; COO, CTO posts to be filled soon
Unicorn ed-tech firm Byju's lays off at least 1,000 more employees across various functions
Tata Trusts appoints Siddharth Sharma as CEO, Aparna Uppaluri as COO
Government to release standards for checking fake reviews on e-commerce, other platforms
Reliance retail, Adani group companies among bidders for Future Retail
